BACKGROUND: Pseudoexfoliation syndrome is a major risk factor for glaucoma in many populations throughout the world. Using a U.S. clinic-based case control sample with broad ethnic diversity, we show that three common SNPs in LOXL1 previously associated with pseudoexfoliation in Nordic populations are significantly associated with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. METHODS: Three LOXL1 SNPs were genotyped in a patient sample (206 pseudoexfoliation, 331 primary open angle glaucoma, and 88 controls) from the Glaucoma Consultation Service at the Massachusetts Eye and Ear Infirmary. The SNPs were evaluation for association with pseudeoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open angle glaucoma. RESULTS: The strongest association was found for the G allele of marker rs3825942 (G153D) with a frequency of 99% in pseudoexfoliation patients (with and without glaucoma) compared with 79% in controls (p = 1.6 x 10-15; OR = 20.93, 95%CI: 8.06, 54.39). The homozygous GG genotype is also associated with pseudoexfoliation when compared to controls (p = 1.2 x 10-12; OR = 23.57, 95%CI: 7.95, 69.85). None of the SNPs were significantly associated with primary open angle glaucoma. CONCLUSION: The pseudoexfoliation syndrome is a common cause of glaucoma. These results indicate that the G153D LOXL1 variant is significantly associated with an increased risk of pseudoexfoliation and pseudoexfoliation glaucoma in an ethnically diverse patient population from the Northeastern United States. Given the high prevalence of pseudooexfoliation in this geographic region, these results also indicate that the G153D LOXL1 variant is a significant risk factor for adult-onset glaucoma in this clinic based population.
BACKGROUND:Pseudoexfoliation syndrome is a major risk factor for glaucoma in many populations throughout the world. Using a U.S. clinic-based case control sample with broad ethnic diversity, we show that three common SNPs in LOXL1 previously associated with pseudoexfoliation in Nordic populations are significantly associated with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. METHODS: Three LOXL1 SNPs were genotyped in a patient sample (206 pseudoexfoliation, 331 primary open angle glaucoma, and 88 controls) from the Glaucoma Consultation Service at the Massachusetts Eye and Ear Infirmary. The SNPs were evaluation for association with pseudeoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open angle glaucoma. RESULTS: The strongest association was found for the G allele of marker rs3825942 (G153D) with a frequency of 99% in pseudoexfoliation patients (with and without glaucoma) compared with 79% in controls (p = 1.6 x 10-15; OR = 20.93, 95%CI: 8.06, 54.39). The homozygous GG genotype is also associated with pseudoexfoliation when compared to controls (p = 1.2 x 10-12; OR = 23.57, 95%CI: 7.95, 69.85). None of the SNPs were significantly associated with primary open angle glaucoma. CONCLUSION: The pseudoexfoliation syndrome is a common cause of glaucoma. These results indicate that the G153D LOXL1 variant is significantly associated with an increased risk of pseudoexfoliation and pseudoexfoliation glaucoma in an ethnically diverse patient population from the Northeastern United States. Given the high prevalence of pseudooexfoliation in this geographic region, these results also indicate that the G153D LOXL1 variant is a significant risk factor for adult-onset glaucoma in this clinic based population.
Authors: J L Wiggs; R R Allingham; A Hossain; J Kern; J Auguste; E A DelBono; B Broomer; F L Graham; M Hauser; M Pericak-Vance; J L Haines Journal: Hum Mol Genet Date: 2000-04-12 Impact factor: 6.150
Authors: Tayebeh Rezaie; Anne Child; Roger Hitchings; Glen Brice; Lauri Miller; Miguel Coca-Prados; Elise Héon; Theodore Krupin; Robert Ritch; Donald Kreutzer; R Pitts Crick; Mansoor Sarfarazi Journal: Science Date: 2002-02-08 Impact factor: 47.728
Authors: R R Allingham; M Loftsdottir; M S Gottfredsdottir; E Thorgeirsson; F Jonasson; T Sverisson; W G Hodge; K F Damji; E Stefánsson Journal: Br J Ophthalmol Date: 2001-06 Impact factor: 4.638
Authors: J L Wiggs; S Lynch; G Ynagi; M Maselli; J Auguste; E A Del Bono; L M Olson; J L Haines Journal: Am J Hum Genet Date: 2004-04-23 Impact factor: 11.025
Authors: Alex W Hewitt; Shiwani Sharma; Kathryn P Burdon; Jie Jin Wang; Paul N Baird; David P Dimasi; David A Mackey; Paul Mitchell; Jamie E Craig Journal: Hum Mol Genet Date: 2007-11-23 Impact factor: 6.150
Authors: Khaled K Abu-Amero; Essam A Osman; Mohammad T Azad; R Rand Allingham; Michael A Hauser; Saleh A Al-Obeidan Journal: Ophthalmic Genet Date: 2011-04-21 Impact factor: 1.803
Authors: Bao J Fan; Louis R Pasquale; Jae H Kang; Hani Levkovitch-Verbin; Jonathan L Haines; Janey L Wiggs Journal: Exp Eye Res Date: 2015-08-10 Impact factor: 3.467
Authors: Haoyu Chen; Li Jia Chen; Mingzhi Zhang; Weifeng Gong; Pancy Oi Sin Tam; Dennis Shun Chiu Lam; Chi Pui Pang Journal: Mol Vis Date: 2010-02-06 Impact factor: 2.367
Authors: Susan E I Williams; Benjamin T Whigham; Yutao Liu; Trevor R Carmichael; Xuejun Qin; Silke Schmidt; Michele Ramsay; Michael A Hauser; R Rand Allingham Journal: Mol Vis Date: 2010-04-21 Impact factor: 2.367
Authors: Georg Mossböck; Martin Weger; Christoph Faschinger; Christine Zimmermann; Otto Schmut; Wilfried Renner; Yosuf El-Shabrawi Journal: Mol Vis Date: 2010-08-28 Impact factor: 2.367
Authors: Tanya T Khan; Guorong Li; Iris D Navarro; Rama D Kastury; Carol J Zeil; Taras M Semchyshyn; Frank J Moya; David L Epstein; Pedro Gonzalez; Pratap Challa Journal: Mol Vis Date: 2010-11-02 Impact factor: 2.367